TFChem Overview
- Founded
-
2007

- Status
-
Acquired/Merged
- Latest Deal Type
-
Debt
- Financing Rounds
-
3
TFChem General Information
Description
Developer of carbohydrate based drugs. The company is mainly engaged in drug discovery using fluorine atom properties to develop new glycomimetic compounds for the treatment of diabetes and obesity, enabling healthcare practitioners to use the compounds in various applications, such as cancer, diabetes, pain and inflammation and cardio-vascular diseases.
Contact Information
Website
ww.tfchemistry.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Voie de l'innovation
- Pharma Parc II Chaussée du Vexin
- 27100 Val de Reuil
- France
TFChem Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
TFChem Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|